Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
Feb 2023
Historique:
pubmed: 6 10 2022
medline: 22 2 2023
entrez: 5 10 2022
Statut: ppublish

Résumé

Incidentally diagnosed adrenal masses represent an entity that can result in either long term follow-up, surgical excision, or both. Understanding when and which adrenal masses are ultimately excised surgically is not well understood. We sought to understand the ultimate fate of these incidentalomas using a large population-based dataset. The primary outcome of the study was determining the trend in adoption of surveillance vs. surgical excision according to socio-demographic, economic, and pathologic indices, and also provider specialty. Secondary outcomes were the assessment of perioperative complications, operative time, surgical approach, hospital stay, and provider specialty (general surgery vs. urology) among the cohort that underwent excision. Out of a total of N.=91,560 adrenal masses, ultimately N.=3375 (3.83%) of these underwent surgical excision. In the surgical excision cohort, the incidence of aldosteronoma, functional adenoma/Cushing's disease, and adrenocortical carcinoma was higher than in the surveillance cohort. Those patients who were older, female, and with higher Charlson Comorbidity indexes (CCI) were less likely to undergo surgical resection. Factors that predicted for an increased probability of resection included obtaining more CT/MRI scans as well as general surgeons as primary physician providers. Over the study period, the vast majority of surgeries were performed by surgeons other than urologists (12.9%) and open and laparoscopic approaches dominated, with the robotic-assisted approach accounting for a minority of the surgical cases (23.9%). The minimally invasive surgery (MIS) approach independently predicted for both lower rates of complications and shorter hospital stay. In the US, adrenal incidentalomas are more likely to undergo surveillance rather than surgical resection. In our study, surgery is mainly offered for functional or malignant disease and the receipt of surgery can vary by physician specialty. A MIS approach independently predicted for both lower rates of complications and shorter hospital stay.

Sections du résumé

BACKGROUND BACKGROUND
Incidentally diagnosed adrenal masses represent an entity that can result in either long term follow-up, surgical excision, or both. Understanding when and which adrenal masses are ultimately excised surgically is not well understood. We sought to understand the ultimate fate of these incidentalomas using a large population-based dataset.
METHODS METHODS
The primary outcome of the study was determining the trend in adoption of surveillance vs. surgical excision according to socio-demographic, economic, and pathologic indices, and also provider specialty. Secondary outcomes were the assessment of perioperative complications, operative time, surgical approach, hospital stay, and provider specialty (general surgery vs. urology) among the cohort that underwent excision.
RESULTS RESULTS
Out of a total of N.=91,560 adrenal masses, ultimately N.=3375 (3.83%) of these underwent surgical excision. In the surgical excision cohort, the incidence of aldosteronoma, functional adenoma/Cushing's disease, and adrenocortical carcinoma was higher than in the surveillance cohort. Those patients who were older, female, and with higher Charlson Comorbidity indexes (CCI) were less likely to undergo surgical resection. Factors that predicted for an increased probability of resection included obtaining more CT/MRI scans as well as general surgeons as primary physician providers. Over the study period, the vast majority of surgeries were performed by surgeons other than urologists (12.9%) and open and laparoscopic approaches dominated, with the robotic-assisted approach accounting for a minority of the surgical cases (23.9%). The minimally invasive surgery (MIS) approach independently predicted for both lower rates of complications and shorter hospital stay.
CONCLUSIONS CONCLUSIONS
In the US, adrenal incidentalomas are more likely to undergo surveillance rather than surgical resection. In our study, surgery is mainly offered for functional or malignant disease and the receipt of surgery can vary by physician specialty. A MIS approach independently predicted for both lower rates of complications and shorter hospital stay.

Identifiants

pubmed: 36197701
pii: S2724-6051.22.05073-X
doi: 10.23736/S2724-6051.22.05073-X
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-84

Auteurs

Francesco Del Giudice (F)

Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy - francesco.delgiudice@uniroma1.it.
Department of Urology, Stanford University School of Medicine, Stanford, CA, USA - francesco.delgiudice@uniroma1.it.

Wansuk Kim (W)

Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.

Shufeng Li (S)

Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.

Ettore DE Berardinis (E)

Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy.

Alessandro Sciarra (A)

Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy.

Stefano Salciccia (S)

Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy.

Matteo Ferro (M)

Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.

Riccardo Autorino (R)

Division of Urology, VCU Health, Richmond, VA, USA.

Savio D Pandolfo (SD)

Division of Urology, VCU Health, Richmond, VA, USA.
Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.

Felice Crocetto (F)

Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.

Antonio Galfano (A)

Department of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paolo Dell'oglio (P)

Department of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Giovanni E Cacciamani (GE)

USC Institute of Urology, University of Southern California, Los Angeles, CA, USA.

Benjamin Pradere (B)

Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France.

Ekaterina Laukhtina (E)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

David D'Andrea (D)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Federico Belladelli (F)

Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Division of Experimental Oncology, Unit of Urology, URI, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.

Wojciech Krajewski (W)

Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Medical University of Wroclaw, Wroclaw, Poland.

Andrea Mari (A)

Unit of Oncologic Minimally Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.

Andrea Minervini (A)

Unit of Oncologic Minimally Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.

Andrea Gallioli (A)

Department of Urology, Puigvert Foundation, Barcelona, Spain.

Daniele Amparore (D)

Department of Urology, San Luigi Hospital, University of Turin, Turin, Italy.

Enrico Checcucci (E)

Department of Urology, San Luigi Hospital, University of Turin, Turin, Italy.

Cristian Fiori (C)

Department of Urology, San Luigi Hospital, University of Turin, Turin, Italy.

Francesco Porpiglia (F)

Department of Urology, San Luigi Hospital, University of Turin, Turin, Italy.

Luca Morgantini (L)

University of Illinois Hospital & Health Sciences System, Chicago, IL, USA.

Simone Crivellaro (S)

University of Illinois Hospital & Health Sciences System, Chicago, IL, USA.

Benjamin I Chung (BI)

Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH